Sign In
Buy A
$137.40
+2.36 (+1.75%)
At Close: Jun 03, 2026
Agilent placed on 'positive catalyst watch' at Citi
06:14am, Monday, 07'th Apr 2025
Citi analyst Patrick Donnelly added a "90-day positive catalyst watch" on shares of Agilent while keeping a Buy rating on the name with a $165 price target. At a time when investor sentiment on tools
Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today
07:00am, Thursday, 03'rd Apr 2025
Fear at extremes: Investor and consumer sentiment is near historic lows, signaling a high-probability buying opportunity, historically followed by strong 12-month gains. Economic reality check: Real-t
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
08:00am, Monday, 24'th Mar 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics' FDA approval for AUCATZYL®, a recently approved CAR T the
CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
01:37pm, Thursday, 20'th Mar 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE N
Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
08:00am, Thursday, 20'th Mar 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is excited to announce its participation at the upcoming United States and Canadian Academy of Pathology (USCAP) Conference, w
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
08:00am, Wednesday, 19'th Mar 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR1,
Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)
03:55pm, Tuesday, 04'th Mar 2025
Agilent Technologies, Inc. (NYSE:A ) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Padraig McDonnell - Chief Executive Officer Bob McMahon - Chief Finan
Unlocking Agilent (A) International Revenues: Trends, Surprises, and Prospects
10:21am, Monday, 03'rd Mar 2025
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Agilent Technologies: Recent Price Weakness Makes This Stock A Buy
02:04am, Saturday, 01'st Mar 2025
Agilent Technologies, a leader in life sciences and diagnostics, has a market cap of $38B and a 10-year CAGR of 13.6%. Key financial metrics: consistent revenue growth, stable gross profit margin abov
Agilent to Participate in TD Cowen Health Care Conference
09:29pm, Thursday, 27'th Feb 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at TD Cowen'
Agilent Technologies, Inc. (A) Q1 2025 Earnings Call Transcript
09:28pm, Wednesday, 26'th Feb 2025
Agilent Technologies, Inc. (NYSE:A ) Q1 2025 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Parmeet Ahuja - Vice President of Investor Relations Padraig McDonnell - Preside
Agilent (A) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
07:00pm, Wednesday, 26'th Feb 2025
Although the revenue and EPS for Agilent (A) give a sense of how its business performed in the quarter ended January 2025, it might be worth considering how some key metrics compare with Wall Street e
Agilent Technologies (A) Q1 Earnings and Revenues Beat Estimates
06:16pm, Wednesday, 26'th Feb 2025
Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.29 per share a year ago.
Agilent lowers annual revenue forecast on soft demand for medical equipment
04:46pm, Wednesday, 26'th Feb 2025
Medical equipment maker Agilent lowered its annual revenue forecast on Wednesday, as it expects soft demand for its medical tools and equipment from smaller biotech companies.
